cisatracurium has been researched along with Intraventricular Septal Defects in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lu, C; Peng, X; Wang, S; Wu, B; Wu, Z; Ye, X | 1 |
Russo, P; Tobias, JD; Torres, J | 1 |
1 trial(s) available for cisatracurium and Intraventricular Septal Defects
Article | Year |
---|---|
Altered Cisatracurium Pharmacokinetics and Pharmacodynamics in Patients with Congenital Heart Defects.
Topics: Adult; Atracurium; Female; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Neuromuscular Blocking Agents; Neuromuscular Junction; Neuromuscular Monitoring; Tissue Distribution; Young Adult | 2016 |
1 other study(ies) available for cisatracurium and Intraventricular Septal Defects
Article | Year |
---|---|
Anaesthetic implications of LEOPARD syndrome.
Topics: Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Atracurium; Cardiopulmonary Bypass; Child, Preschool; Fentanyl; Heart Septal Defects, Ventricular; Humans; LEOPARD Syndrome; Male; Methyl Ethers; Neuromuscular Blocking Agents; Perioperative Care; Pulmonary Valve; Pulmonary Valve Stenosis; Sevoflurane | 2004 |